Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Common errors and controversies in pharmacoeconomic analyses.

S Byford1, S Palmer

  • 1Centre for Health Economics, University of York, England. sb33@york.ac.uk

Pharmacoeconomics
|May 7, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic hydroxychloroquine retinopathy monitoring programme: cost benefit comparing to a hospital-based system.

Eye (London, England)·2024
Same author

CLEAR - clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings.

BMC psychiatry·2024
Same author

Development of a highly sensitive and specific intact proviral DNA assay for HIV-1 subtype B and C.

Virology journal·2024
Same author

Identifying core components of a radiotherapy comfort intervention package using nominal group technique.

Radiography (London, England : 1995)·2023
Same author

Nursing, midwifery, and allied health professions research capacities and cultures: a survey of staff within a university and acute healthcare organisation.

BMC health services research·2023
Same author

Online activity - A beaming good initiative! Delivering alternative exercise opportunities for people with cystic fibrosis.

Physiotherapy theory and practice·2023
Same journal

Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia.

PharmacoEconomics·2026
Same journal

Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update.

PharmacoEconomics·2026
Same journal

Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.

PharmacoEconomics·2026
Same journal

A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations.

PharmacoEconomics·2026
Same journal

Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration.

PharmacoEconomics·2026
Same journal

Correction: Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group.

PharmacoEconomics·2026
See all related articles

Pharmacoeconomics uses economic tools to assess healthcare interventions. Accurate economic evaluations require quality data, appropriate methods, and clear results presentation to ensure optimal resource allocation.

Area of Science:

  • Health Economics
  • Pharmaceutical Policy

Background:

  • The increasing need for cost-effectiveness in healthcare drives the use of economic evaluations in pharmaceutical assessments.
  • Pharmacoeconomics aids early viability predictions, pricing, reimbursement, and formulary decisions.

Purpose of the Study:

  • To highlight the critical components of robust economic evaluations in healthcare.
  • To identify areas of confusion and dispute that impact the accuracy of economic assessments.

Main Methods:

  • Discusses the essential elements for credible economic evaluations: clinical data quality, cost-outcome measurement, and data analysis techniques.
  • Emphasizes the importance of trial design, sample size, perspective, and appropriate statistical, incremental, and sensitivity analyses.

Related Experiment Videos

Main Results:

  • Accurate economic evaluations depend on relevant clinical data, credible cost and outcome measures, and sound analytical methods.
  • Effective presentation of results is crucial for maximizing generalizability and research utility.

Conclusions:

  • Economic evaluations are vital for resource allocation but face challenges in data quality and methodology.
  • Understanding and addressing areas of confusion can minimize errors and enhance the reliability of pharmacoeconomic research.